Saturday, July 20, 2019 12:09:57 PM
Direct changes the tumor microenvironment, is programmed to lower cancer cell defenses and signaling cuts off tumor growth. When a tumor can't grow it dies and leaves necrotic tumor mass in it's wake. Sound familiar? When we all see how it works this time without handcuffs on we will not want to sell a share. I believe the Direct trial must get started to convince existing supporters not to sell to those who want derisked shares on the cheap. We know they are out there. I expect the Direct trial to start in August to help create a steady stream of news that convinces longs to mostly hold through initial news from L. I also believe Linda had money to get to the finish line with L but took out this money to get Direct started and improve a news stream that longs were promised would come. I am convinced this financing was a strategic move by Linda and friendlies were called upon to participate. Until a news stream happens, though, the bears have been given the upper hand.
Going back to L for a minute, think about the importance of what has happened in Germany. The hold continues there, more than once Fraunhofer claimed to have optimized L including since the hold (you don't optimize a placebo as some would indirectly try to convince us) and the Germans did not fill their SOC/placebo cohort but did fill their treatment cohort. They referrenced this move as statistically sufficient even though powering was reduced. Think about that for a second: ). Couple this with improving 3 year outcomes in line with expectations of treatment effect and a late forming enrollment ratio discrepancy favoring treatment and the evidence becomes quite compelling.
Bears want us to look in a different direction than the obvious. Their perspective is that patients can't be known to benefit until L clears the hurdles of the process and crosses the finish line. Their goal has neen to pressure NWBO to prove L works and suppress the price until they do. In their view nice stories from patients are great to hear but their stories don't change the data for the entire group and the way Linda Powers runs the business by holding on to some key information and over promising and under delivering just makes it easy for them to make her look bad so why not. What they fail to mention is that what Linda, Fraunhofer and others have given us is enough to connect the dots. Anyone who has been on this board for a while knows sentiment-stocks, flipper44 and a few others have done a yeoman's job of that. Best wishes.
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM